MnmC is a bifunctional enzyme that catalyzes the last two steps in the biosynthesis of mnm5s2U in tRNA. It consists of two domains: an N-terminal methyltransferase domain and a C-terminal FAD-dependent oxidoreductase domain. The N-terminal domain is responsible for methylation, utilizing S-adenosylmethionine (SAM) as a cofactor, while the C-terminal domain performs the oxidation step, requiring FAD as a cofactor .
| Domain | Function | Cofactor |
|---|---|---|
| N-terminal | Methylation | SAM |
| C-terminal | Oxidation | FAD |
The biosynthesis of mnm5s2U involves several steps, starting from the modification of uridine at position 34 in tRNA. The MnmEG complex initiates this process by adding a carboxymethylaminomethyl (cmnm) group to the uridine, which is then converted into nm5 by MnmC's oxidoreductase domain. Finally, the methyltransferase domain of MnmC methylates nm5 to form mnm5s2U .
tRNA modifications like mnm5s2U are crucial for maintaining the structural integrity and decoding accuracy of tRNA during protein synthesis. These modifications help in stabilizing the tRNA structure, ensuring proper codon recognition, and preventing frameshifting during translation .
While specific research on the recombinant MnmC from Pseudomonas syringae pv. syringae is limited, studies on MnmC in Escherichia coli highlight its importance in bacterial physiology. The development of recombinant forms of such enzymes could have implications for understanding bacterial metabolism and potentially for biotechnological applications.
KEGG: psb:Psyr_3742
STRING: 205918.Psyr_3742
The bifunctional activity of MnmC involves two enzymatic steps: (1) methylation of cmnm⁵s²U34 to nm⁵s²U34 and (2) oxidation of nm⁵s²U34 to mnm⁵s²U34 . To study this, researchers should employ high-performance liquid chromatography (HPLC) paired with selectively under-modified tRNA substrates. For example, kinetic assays using purified recombinant MnmC revealed a Kₘ of 600 nM and kₐₜ of 0.34 s⁻¹ for the first step, and Kₘ of 70 nM and kₐₜ of 0.31 s⁻¹ for the second step . This method ensures precise quantification of intermediate and final products.
Functional validation requires activity assays and mass spectrometry. For instance, recombinant MnmC from P. syringae expressed in E. coli should retain both methyltransferase and oxidoreductase activities . Activity can be confirmed using tRNA hydrolysates from mnmC-deficient strains, followed by HPLC to detect mnm⁵s²U34 formation . Mass spectrometry further verifies post-translational modifications, such as FAD binding, critical for the oxidoreductase domain .
Essential controls include:
Substrate-negative controls: tRNA extracts from mnmC knockout strains.
Enzyme-negative controls: Reactions without MnmC or with heat-inactivated enzyme.
Intermediate spiking: Adding synthetic nm⁵s²U34 to confirm HPLC detection limits .
These controls mitigate false positives from endogenous tRNA modifications or non-enzymatic reactions.
Comparative genomic analyses reveal that MnmC orthologs in P. syringae pathovars (e.g., pv. syringae vs. pv. tabaci) exhibit sequence divergence in substrate-binding pockets . For example, residue substitutions (e.g., Gly→Asp at position 212) may alter FAD orientation, impacting oxidoreductase activity . Researchers should perform site-directed mutagenesis on recombinant MnmC variants and compare kinetic parameters using steady-state assays .
Discrepancies in Kₘ and kₐₜ values often arise from differences in tRNA substrate preparation (e.g., synthetic vs. native tRNA) or assay conditions (e.g., pH, ionic strength) . To address this:
Standardize tRNA extraction protocols (e.g., using P. syringae wild-type vs. ΔmnmC strains).
Perform assays under physiologically relevant conditions (e.g., 25°C, pH 7.4 for plant apoplast environments) .
Use isothermal titration calorimetry (ITC) to directly measure binding affinities independent of catalytic turnover .
MnmC operates downstream of the GidA-MnmE complex, which synthesizes cmnm⁵s²U34 . In P. syringae, disruptions in this pathway attenuate virulence by impairing tRNA modification critical for effector蛋白 secretion . To study interactions:
Use bacterial two-hybrid assays to test physical binding between MnmC and GidA/MnmE.
Conduct transcriptomic profiling of ΔmnmC strains during plant infection to identify dysregulated virulence genes .
This dichotomy arises from conditional essentiality. For example, MnmC is dispensable in nutrient-rich media but critical under host-mimicking stress (e.g., oxidative stress, low iron) . Researchers should:
Perform phenotypic complementation assays in defined media lacking specific nutrients.
Use RNA-seq to compare tRNA modification levels in ΔmnmC strains across growth conditions .
While MnmC primarily modifies tRNA, its genomic proximity to ice nucleation (ina) genes in some strains suggests coregulation . To test this:
Construct double mutants (ΔmnmC ΔinaZ) and quantify ice nucleation activity using droplet freezing assays .
Perform chromatin immunoprecipitation (ChIP) to identify shared transcriptional regulators.
Stopped-flow spectroscopy: Track FAD redox states during the oxidoreductase step .
Single-molecule FRET: Observe conformational changes during tRNA binding and catalysis .
CRISPRi allows titratable suppression of mnmC expression without full knockout:
Design sgRNAs targeting the mnmC promoter or coding sequence.
Measure dose-dependent effects on tRNA modification and virulence using LC-MS/MS and plant infection assays .
| Step | Substrate | Kₘ (nM) | kₐₜ (s⁻¹) | Source |
|---|---|---|---|---|
| Methylation | cmnm⁵s²U34 | 600 ± 40 | 0.34 ± 0.02 | |
| Oxidation | nm⁵s²U34 | 70 ± 10 | 0.31 ± 0.03 |